21P Molecular Characterization of Early-Stage Her2-Overexpressing Breast Cancer (Her2+ Bc) Treated with Adjuvant Trastuzumab: Identification of Prognostic Groups
Titel:
21P Molecular Characterization of Early-Stage Her2-Overexpressing Breast Cancer (Her2+ Bc) Treated with Adjuvant Trastuzumab: Identification of Prognostic Groups
Auteur:
Fumagalli, D. Lambrechts, D. Neven, P. Vanderhaegen, J. Claes, B. Singhal, S.K. Piccart, M. Michiels, S. Sotiriou, C. Loi, S.